estriol has been researched along with Chromosomal Triplication in 65 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of a dialysate of calf blood in the treatment of chronic placental insufficiency is assessed using the urinary oestriol elimination as parameter." | 9.05 | [The effect of calf blood dialysate on the excretion of estriol in placental insufficiency]. ( Bernaschek, G; Schaller, A; Spernol, R, 1984) |
| "Testing for trisomy 18 was recommended for patients with an alpha-fetoprotein < or = 0." | 6.67 | A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. ( Burton, BK; Prins, GS; Verp, MS, 1993) |
| "The efficacy of a dialysate of calf blood in the treatment of chronic placental insufficiency is assessed using the urinary oestriol elimination as parameter." | 5.05 | [The effect of calf blood dialysate on the excretion of estriol in placental insufficiency]. ( Bernaschek, G; Schaller, A; Spernol, R, 1984) |
| " Search terms included PAPP-A (pregnancy associated plasma protein A), AFP (alphafetoprotein), hCG (human chorionic gonadotropin), estriol, unconjugated estriol, inhibin, inhibin-A, maternal serum screen, triple marker screen, quadruple screen, integrated prenatal screen, first trimester screen, and combined prenatal screen." | 4.84 | Obstetrical complications associated with abnormal maternal serum markers analytes. ( Gagnon, A; Wilson, RD, 2008) |
| " Serum analytes (pregnancy associated plasma protein A [PAPP-A], hCG, creatinine [Cr], and alanine aminotransferase [ALT]) were drawn at approximately 12 weeks' gestation, and alpha-fetoprotein and unconjugated estriol were drawn at 16 weeks' gestation." | 3.77 | Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures. ( Nisenbaum, R; Ray, JG; Wyatt, PR; Ying, I, 2011) |
| "The best combination of serum markers includes pregnancy-associated plasma protein-A in the first trimester and alpha-fetoprotein, unconjugated estriol and human chorionic gonadotropin in the second trimester." | 3.72 | Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers. ( Haddow, JE; Knight, GJ; Neveux, LM; Palomaki, GE, 2003) |
| "to review the contribution of unconjugated estriol in Down's syndrome detection, and influence of maternal age, cut-off choice, and population specificity on the balance between triple-marker test sensitivity and specificity." | 3.70 | The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity. ( Huderer-Duric, K; Kuvacic, I; Rubala, D; Skrablin, S; Sonicki, Z; Suchanek, E, 2000) |
| "A retrospective evaluation of alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), and unconjugated oestriol (uE3) levels in maternal blood in the second trimester was conducted for cases of aneuploid pregnancies identified from a series of women who underwent amniocentesis." | 3.69 | A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. ( Murakami, I; Natori, M; Okada, S; Sato, A; Suzumori, K; Takagi, T; Tanaka, M; Tanemura, M, 1997) |
| "Information on maternal age and maternal serum alpha-fetoprotein, unconjugated oestriol (uE3), and human chorionic gonadotrophin (hCG) levels was used to investigate retrospectively the effect of estimating Edward's syndrome risk in women having multi-marker screening for Down's syndrome." | 3.68 | Expanding multiple marker screening for Down's syndrome to include Edward's syndrome. ( Barkai, G; Chaki, R; Cuckle, H; Goldman, B; Ries, L; Zer, T, 1993) |
| "Testing for trisomy 18 was recommended for patients with an alpha-fetoprotein < or = 0." | 2.67 | A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. ( Burton, BK; Prins, GS; Verp, MS, 1993) |
| "Six cases of trisomy 18 and one case of Turner syndrome were identified by karyotype." | 2.67 | Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. ( Canick, JA; Haddow, JE; Knight, GJ; Palomaki, GE; Panizza, DS; Saller, DN, 1992) |
| "The fetus had intrauterine growth restriction, seen early in the second trimester, oligohydramnios, and was delivered at 34 weeks of gestation for impending fetal compromise." | 2.44 | False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome. ( Baxi, L; Brown, S; Thaker, HM, 2007) |
| "The detection rate of trisomy 18 among patients offered amniocentesis was significantly lower (p < 0." | 2.40 | Prospective evaluation of prenatal maternal serum screening for trisomy 18. ( Budelier, WT; Fulton, A; Grant, SS; Williamson, R; Yankowitz, J, 1998) |
| "We selected 14 cases of trisomy 18 and 3 cases of SLO in which the maternal uE(3) level was decreased and reported malformations were observed after fetopathological examination." | 1.40 | Involvement and alteration of the Sonic Hedgehog pathway is associated with decreased cholesterol level in trisomy 18 and SLO amniocytes. ( Bigot, N; Galera, P; Gruchy, N; Jeanne Pasquier, C; Leporrier, N; Odent, S; Read, MH, 2014) |
| "The DR for trisomy 21 in California's statewide quadruple-marker screening is very similar to the Program's previously reported DR using triple-marker screening." | 1.37 | Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. ( Currier, RJ; Flessel, M; Goldman, S; Hennigan, C; Hodgkinson, C; Kazerouni, NN; Lorey, F; Malm, L; Roberson, M; Tempelis, C, 2011) |
| "The pregnancy was largely uncomplicated except for an abnormal triple screen, with subsequent normal amniocentesis, and a fetal ultrasound revealing a clubfoot anomaly." | 1.32 | Fertility in a female with mosaic trisomy 8. ( Cotter, PD; Golabi, M; Rauen, KA, 2003) |
| "A higher incidence of trisomy 13 (12." | 1.32 | The implications of a false positive second-trimester serum screen for Down syndrome. ( Huang, T; Meier, C; Summers, AM; Wyatt, PR, 2003) |
| "This represented 65% of all trisomy 18 screen-positive patients who had follow-up services at any of 117 Californian state-approved Prenatal Diagnosis Centers during a six-month period from November 1, 1995 to April 30, 1996." | 1.31 | Prenatal ultrasound findings in affected and unaffected pregnancies that are screen-positive for trisomy 18: the California experience. ( Cunningham, GC; Currier, RJ; Feuchtbaum, LB; Lorey, FW, 2000) |
| "However, approximately 6-10% of trisomy 18 affected pregnancies will be screen-positive for Down syndrome but screen-negative for trisomy 18." | 1.31 | Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. ( Beazoglou, T; Benn, PA; Egan, JF; Ying, J, 2001) |
| "To determine if a false-positive trisomy 18 multiple-marker screening test (all three analytes low: maternal serum alpha-fetoprotein [AFP] at most 0." | 1.30 | Significance of a false-positive trisomy 18 multiple-marker screening test. ( Brumfield, CG; Davis, RO; Dubard, M; Garcia, T; Owen, J; Wenstrom, KD, 1997) |
| "Twenty-one cases of trisomy 18, 10 cases of Turner syndrome without hydrops and 12 cases of Turner syndrome with hydrops were identified." | 1.30 | Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops. ( Canick, JA; French, CA; Lambert-Messerlian, GM; Peterson, CJ; Saller, DN; Tumber, MB, 1998) |
| "Pregnancies with trisomy 13 were identified through cytogenetics laboratories." | 1.30 | Second-trimester maternal serum analyte levels associated with fetal trisomy 13. ( Blakemore, KJ; Blitzer, MG; Canick, JA; Haddow, JE; Palomaki, GE; Saller, DN; Schwartz, S, 1999) |
| "Even though the birth prevalence of trisomy 18 is low, prenatal screening can be justified when performed in conjunction with Down syndrome screening and when a high proportion of women offered amniocentesis have an affected fetus." | 1.29 | Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. ( Blitzer, MG; Canick, JA; Dickerman, LH; Fisher, R; Haddow, JE; Kennard, A; Knight, GJ; Palomaki, GE; Saller, DN; Wald, NJ, 1995) |
| "For the detection of one infant with trisomy 18 that will survive past five months, 25 normal fetuses would be lost owing to amniocentesis." | 1.29 | Prenatal sonographic detection of isolated fetal choroid plexus cysts: should we screen for trisomy 18? ( Donnenfeld, AE, 1995) |
| "Four trisomy 18 pregnancies had UE3 levels less than 0." | 1.29 | Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. ( Aitken, DA; Connor, JM; Crossley, JA, 1993) |
| "In addition, ll cases of trisomy 18 identified prenatally in two other centres were included." | 1.29 | The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18. ( Herlicoviez, M; Herrou, M; Leporrier, N; Leymarie, P, 1996) |
| "Although trisomy 16 cells could not be clearly demonstrated in the fetus, the presence of a clinically significant proportion of aneuploid cells early in development could not be excluded and it therefore cannot be assumed that a 'confined placental mosaicism' existed." | 1.29 | Trisomy 16 mosaicism in amniotic fluid cell cultures. ( Benn, P; Craffey, A; Delach, J; Matsumoto, C; Smeltzer, J; Tantravahi, U, 1996) |
| "The alpha-fetoprotein levels in the 10 trisomy 18 pregnancies without open neural tube or ventral wall defect had a median of 0." | 1.28 | Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies. ( Alpert, E; Darnule, AT; Greenberg, F; Rose, E; Schmidt, D; Weyland, BR, 1992) |
| "We report on 2 patients with trisomy 18 fetuses in whom antenatal screening showed extremely low hCG levels (0." | 1.28 | Human chorionic gonadotrophin and trisomy 18. ( Barkai, G; Chaki, R; Goldman, B; Sochat, M, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.08) | 18.7374 |
| 1990's | 25 (38.46) | 18.2507 |
| 2000's | 29 (44.62) | 29.6817 |
| 2010's | 8 (12.31) | 24.3611 |
| 2020's | 1 (1.54) | 2.80 |
| Authors | Studies |
|---|---|
| Wyness, SP | 1 |
| Snow, TM | 1 |
| Villanueva, M | 1 |
| Kunzler, T | 1 |
| Seiter, J | 1 |
| Genzen, JR | 1 |
| Johnson, LM | 1 |
| Chong, R | 1 |
| Rho, JE | 1 |
| Yoon, HJ | 1 |
| Park, PS | 1 |
| Rho, TH | 1 |
| Park, JY | 1 |
| Park, L | 1 |
| Kim, YH | 1 |
| Lee, JH | 1 |
| Chasen, ST | 1 |
| Gruchy, N | 1 |
| Bigot, N | 1 |
| Jeanne Pasquier, C | 1 |
| Read, MH | 1 |
| Odent, S | 1 |
| Galera, P | 1 |
| Leporrier, N | 2 |
| Hu, Z | 1 |
| Liu, X | 1 |
| Li, L | 1 |
| Jia, C | 1 |
| Li, D | 1 |
| Liu, R | 1 |
| Jelliffe-Pawlowski, LL | 2 |
| Walton-Haynes, L | 2 |
| Currier, RJ | 4 |
| Gagnon, A | 1 |
| Wilson, RD | 1 |
| Koide, K | 1 |
| Slonim, DK | 1 |
| Johnson, KL | 1 |
| Tantravahi, U | 2 |
| Cowan, JM | 1 |
| Bianchi, DW | 1 |
| Kazerouni, NN | 1 |
| Flessel, M | 1 |
| Goldman, S | 1 |
| Hennigan, C | 1 |
| Hodgkinson, C | 1 |
| Lorey, F | 1 |
| Malm, L | 1 |
| Tempelis, C | 1 |
| Roberson, M | 1 |
| Sarıkaya, E | 1 |
| Bozdağ, S | 1 |
| Deveer, R | 1 |
| Oğuz, SS | 1 |
| Dilmen, U | 1 |
| Mollamahmutoglu, L | 1 |
| Ying, I | 1 |
| Wyatt, PR | 5 |
| Nisenbaum, R | 1 |
| Ray, JG | 1 |
| Graf, MD | 1 |
| Gill, P | 1 |
| Krew, M | 1 |
| Schwartz, S | 2 |
| Rauen, KA | 1 |
| Golabi, M | 1 |
| Cotter, PD | 1 |
| Palomaki, GE | 5 |
| Neveux, LM | 1 |
| Knight, GJ | 3 |
| Haddow, JE | 4 |
| Summers, AM | 5 |
| Huang, T | 5 |
| Meier, C | 3 |
| Farrell, SA | 1 |
| Alberman, E | 1 |
| Wald, N | 1 |
| Owolabi, T | 1 |
| Celentano, C | 1 |
| Guanciali-Franchi, PE | 1 |
| Liberati, M | 1 |
| Prefumo, F | 1 |
| Palka, G | 1 |
| Rotmensch, S | 1 |
| Serdar, MA | 1 |
| Tütüncü, L | 1 |
| Olgun, A | 1 |
| Haşimi, A | 1 |
| Ozgurtaş, T | 1 |
| Erbil, MK | 1 |
| Husseini, A | 1 |
| Akkawi, M | 1 |
| Ciszko, B | 1 |
| Zdrojewicz, Z | 1 |
| Begleiter, ML | 1 |
| Lund, MM | 1 |
| Atherton, AM | 1 |
| Buchholz, JD | 1 |
| Ardinger, HH | 1 |
| Baxi, L | 1 |
| Brown, S | 1 |
| Thaker, HM | 1 |
| Bernaschek, G | 1 |
| Spernol, R | 1 |
| Schaller, A | 1 |
| Wald, NJ | 2 |
| Kennard, A | 1 |
| Canick, JA | 6 |
| Saller, DN | 4 |
| Blitzer, MG | 2 |
| Dickerman, LH | 1 |
| Fisher, R | 1 |
| Donnenfeld, AE | 1 |
| Barkai, G | 2 |
| Goldman, B | 2 |
| Ries, L | 1 |
| Chaki, R | 2 |
| Zer, T | 1 |
| Cuckle, H | 3 |
| Valerio, D | 1 |
| Crossley, JA | 1 |
| Aitken, DA | 2 |
| Connor, JM | 1 |
| Burton, BK | 1 |
| Prins, GS | 1 |
| Verp, MS | 1 |
| Herrou, M | 1 |
| Herlicoviez, M | 1 |
| Leymarie, P | 1 |
| Reynolds, TM | 1 |
| Wierzbicki, A | 1 |
| Matsumoto, C | 1 |
| Delach, J | 1 |
| Craffey, A | 1 |
| Smeltzer, J | 1 |
| Benn, P | 1 |
| Spencer, K | 1 |
| Muller, F | 1 |
| Ariel, I | 1 |
| Lerer, I | 1 |
| Yagel, S | 1 |
| Cohen, R | 1 |
| Ben-Neriah, Z | 1 |
| Abeliovich, D | 1 |
| Suzumori, K | 1 |
| Tanemura, M | 1 |
| Murakami, I | 1 |
| Okada, S | 1 |
| Natori, M | 1 |
| Tanaka, M | 1 |
| Takagi, T | 1 |
| Sato, A | 3 |
| Wenstrom, KD | 2 |
| Owen, J | 2 |
| Brumfield, CG | 1 |
| Davis, RO | 1 |
| Dubard, M | 1 |
| Garcia, T | 1 |
| Yankowitz, J | 1 |
| Fulton, A | 1 |
| Williamson, R | 1 |
| Grant, SS | 1 |
| Budelier, WT | 1 |
| Eubanks, SR | 1 |
| Kuller, JA | 1 |
| Amjadi, D | 1 |
| Powell, CM | 1 |
| Lambert-Messerlian, GM | 2 |
| Tumber, MB | 1 |
| French, CA | 1 |
| Peterson, CJ | 1 |
| Chu, Dc | 1 |
| Boots, L | 1 |
| Blakemore, KJ | 1 |
| Huderer-Duric, K | 1 |
| Skrablin, S | 1 |
| Kuvacic, I | 1 |
| Sonicki, Z | 1 |
| Rubala, D | 1 |
| Suchanek, E | 1 |
| Feuchtbaum, LB | 1 |
| Lorey, FW | 1 |
| Cunningham, GC | 1 |
| Moroz, C | 1 |
| Maymon, R | 1 |
| Jauniaux, E | 1 |
| Traub, L | 1 |
| Benn, PA | 3 |
| Leo, MV | 1 |
| Rodis, JF | 2 |
| Beazoglou, T | 2 |
| Collins, R | 1 |
| Horne, D | 1 |
| Yoshida, K | 2 |
| Kuwabara, Y | 1 |
| Tanaka, T | 2 |
| Onda, T | 2 |
| Kudo, R | 2 |
| Yamamoto, H | 2 |
| Yanagida, K | 2 |
| Okai, T | 2 |
| Sakai, M | 2 |
| Takai, Y | 2 |
| Uemura, H | 2 |
| Hoshi, K | 2 |
| Fukada, Y | 2 |
| Aono, T | 2 |
| Maeda, K | 2 |
| Ogita, S | 2 |
| Ishiko, O | 1 |
| Murata, Y | 2 |
| Kanzaki, T | 2 |
| Myrick, F | 2 |
| Grier, RE | 2 |
| Rausch, DN | 1 |
| Nakamura, Y | 1 |
| Miyake, Y | 1 |
| Ohnishi, M | 1 |
| Kaneoka, T | 1 |
| Makino, Y | 1 |
| Kanzaki, H | 1 |
| Osaki, T | 1 |
| Yamamasu, S | 1 |
| Aso, T | 1 |
| Shimizu, Y | 2 |
| Izutsu, T | 1 |
| Kudo, T | 1 |
| Hashimoto, T | 1 |
| Matsuzaki, N | 1 |
| Kitagawa, M | 1 |
| Sago, H | 1 |
| Ying, J | 1 |
| Egan, JF | 2 |
| Hackshaw, AK | 1 |
| Akbas, SH | 1 |
| Ozben, T | 1 |
| Alper, O | 1 |
| Ugur, A | 1 |
| Yücel, G | 1 |
| Lüleci, G | 1 |
| Hogge, WA | 1 |
| Fraer, L | 1 |
| Melegari, T | 1 |
| Gainey, A | 1 |
| Ingardia, CJ | 1 |
| Graves, JC | 1 |
| Miller, KE | 1 |
| Sellers, AD | 1 |
| Panizza, DS | 1 |
| Greenberg, F | 1 |
| Schmidt, D | 1 |
| Darnule, AT | 1 |
| Weyland, BR | 1 |
| Rose, E | 1 |
| Alpert, E | 1 |
| Mason, G | 1 |
| Linton, G | 1 |
| Holding, S | 1 |
| Osathanondh, R | 1 |
| Sochat, M | 1 |
| Zolotukhina, TV | 1 |
| Kuznetsov, MI | 1 |
| Kostiuk, EV | 1 |
| Shilova, NV | 1 |
| Solonichenko, VG | 1 |
| Macafee, CA | 1 |
| Fortune, DW | 1 |
| Beischer, NA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Induction of Labor at Term Versus Expectant Management Among Women With Abnormal Maternal Serum Biochemical Markers: A Randomized Controlled Trial[NCT02754635] | 320 participants (Anticipated) | Interventional | 2016-03-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for estriol and Chromosomal Triplication
| Article | Year |
|---|---|
Maternal serum analyte screening for fetal aneuploidy.
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosome | 2014 |
Obstetrical complications associated with abnormal maternal serum markers analytes.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Humans; Inhibins; Pregnancy | 2008 |
[Compliance endogenous and exogenous estriol in clinical practice].
Topics: Abnormalities, Multiple; Adult; Chromosomes, Human, Pair 18; Down Syndrome; Estriol; Female; Humans; | 2006 |
False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Bloom Syndrome; Cesarean Section, Repeat; Chor | 2007 |
Prospective evaluation of prenatal maternal serum screening for trisomy 18.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estri | 1998 |
Second trimester maternal serum analytes in triploid pregnancies: correlation with phenotype and sex chromosome complement.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Humans; Inhibins; Ph | 2001 |
3 trials available for estriol and Chromosomal Triplication
| Article | Year |
|---|---|
[The effect of calf blood dialysate on the excretion of estriol in placental insufficiency].
Topics: Actihaemyl; Bed Rest; Chromosomes, Human, 16-18; Estriol; Female; Humans; Placenta Diseases; Placent | 1984 |
A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Topics: Adolescent; Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chromosome | 1993 |
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Chr | 1992 |
56 other studies available for estriol and Chromosomal Triplication
| Article | Year |
|---|---|
Impact of Unconjugated estriol (uE3) assay interference on prenatal screening tests.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Preg | 2022 |
Role of Triton X-100 in chemiluminescent enzyme immunoassays capable of diagnosing genetic disorders.
Topics: alpha-Fetoproteins; Calibration; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syndrome; | 2013 |
Involvement and alteration of the Sonic Hedgehog pathway is associated with decreased cholesterol level in trisomy 18 and SLO amniocytes.
Topics: Amniotic Fluid; Atorvastatin; Bone Morphogenetic Protein 2; Cells, Cultured; Cholesterol; Chromosome | 2014 |
[Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Topics: Amniocentesis; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosomes, Human, Pair 18; | 2014 |
Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Chromosomes, Hu | 2008 |
Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Case-Control Studies; Chorionic Gonadotropin, beta Subunit, H | 2009 |
Transcriptomic analysis of cell-free fetal RNA suggests a specific molecular phenotype in trisomy 18.
Topics: Adrenal Glands; Algorithms; Chromosomes, Human, Pair 18; DNA Repair; Down-Regulation; Endocardial Cu | 2011 |
Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009.
Topics: Adult; alpha-Fetoproteins; Biomarkers; California; Chorionic Gonadotropin; Chromosome Aberrations; C | 2011 |
Possible association of medications during pregnancy with low estriol level of the triple antenatal screening test.
Topics: Adult; Antithyroid Agents; Congenital Abnormalities; Cross-Sectional Studies; Estriol; False Positiv | 2012 |
Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.
Topics: Alanine Transaminase; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Creatinine; Cross-Sect | 2011 |
Prenatal detection of structural abnormalities of chromosome 18: associations with interphase fluorescence in situ hybridization (FISH) and maternal serum screening.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Amniotic Fluid; Chorionic Gonadotropin; Chromosome Aberrat | 2002 |
Fertility in a female with mosaic trisomy 8.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosomes, Human, Pair 8; Clubfo | 2003 |
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Topics: Algorithms; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Est | 2003 |
The implications of a false positive second-trimester serum screen for Down syndrome.
Topics: Abortion, Spontaneous; Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Case-Control Studies; C | 2003 |
Maternal serum screening in Ontario using the triple marker test.
Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosomes, Huma | 2003 |
Triploidy identified through second-trimester serum screening.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syn | 2005 |
The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syndrome; Estriol; Fem | 2005 |
Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
Topics: Abortion, Eugenic; Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human | 2005 |
The effects of analytical factors on second trimester risk estimations.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, 16-18; Down Syndr | 2006 |
Maternal serum screening of Palestinian women in the West Bank.
Topics: Adolescent; Adult; alpha-Fetoproteins; Bias; Chi-Square Distribution; Chorionic Gonadotropin; Chromo | 2005 |
Maternal serum screening and 22q11.2 deletion syndrome.
Topics: Abnormalities, Multiple; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human | 2007 |
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Topics: Adult; Algorithms; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syn | 1995 |
Prenatal sonographic detection of isolated fetal choroid plexus cysts: should we screen for trisomy 18?
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Brain Diseases; Chorionic Gonadotropin; Choroid Plexus; | 1995 |
Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome | 1993 |
Maternal serum screening and triploidy.
Topics: Abnormalities, Multiple; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Estriol; Female; Humans; | 1994 |
Second-trimester unconjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay.
Topics: alpha-Fetoproteins; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 18; Down | 1993 |
The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Topics: Adult; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estriol; Female; Humans; Middle Aged; Pr | 1996 |
Prenatal screening for trisomy 18.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estriol; False | 1996 |
Trisomy 16 mosaicism in amniotic fluid cell cultures.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Amniotic Fluid; Cells, Cultured; Chorionic Gonadotropin; C | 1996 |
Biochemical markers of trisomy 21 in amniotic fluid.
Topics: Adult; alpha-Fetoproteins; Amniotic Fluid; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estrio | 1997 |
Trisomy 2: confined placental mosaicism in a fetus with intrauterine growth retardation.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin, beta Subunit, Human; Chromosomes, | 1997 |
A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Topics: Adult; Algorithms; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Chromosomes, Human, Pair | 1997 |
Significance of a false-positive trisomy 18 multiple-marker screening test.
Topics: Adult; alpha-Fetoproteins; Bias; Case-Control Studies; Chorionic Gonadotropin; Chromosomes, Human, P | 1997 |
Prenatal diagnosis of mosaic trisomy 13: a case report.
Topics: Abortion, Induced; Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosomes, Hu | 1998 |
Second-trimester maternal serum inhibin A levels in fetal trisomy 18 and Turner syndrome with and without hydrops.
Topics: alpha-Fetoproteins; Blood Preservation; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Cryopre | 1998 |
Prospective evaluation of free beta-subunit of human chorionic gonadotropin and dimeric inhibin A for aneuploidy detection.
Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Chorionic Gonadotropin; Chorionic Gonadotropin, beta | 1999 |
Second-trimester maternal serum analyte levels associated with fetal trisomy 13.
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 13; Estriol; | 1999 |
The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Topics: Adult; Age Factors; alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropi | 2000 |
Prenatal ultrasound findings in affected and unaffected pregnancies that are screen-positive for trisomy 18: the California experience.
Topics: alpha-Fetoproteins; California; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estriol; Female | 2000 |
Screening for trisomies 21 and 18 with maternal serum placental isoferritin p43 component.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin, beta Subunit, Human; Chromosomes, Human, Pair 18; Down S | 2000 |
Maternal serum screening for fetal trisomy 18: a comparison of fixed cutoff and patient-specific risk protocols.
Topics: Abnormalities, Multiple; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair | 1999 |
Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Dimerization; D | 2000 |
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.
Topics: alpha-Fetoproteins; Anxiety; Biomarkers; Chi-Square Distribution; Chorionic Gonadotropin; Chromosome | 2000 |
Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pa | 2000 |
Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Computer | 2001 |
Revised distribution parameters for serum markers for trisomy 18.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; | 2000 |
Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
Topics: Adolescent; Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosomes, Human, Pa | 2001 |
Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosomes, Human, Pair | 2001 |
Maternal serum triple analyte screening in pregnancy.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Estriol; Female; Genetic Counseling; Humans; Neur | 2002 |
Pregnancy outcomes of women with positive serum screening results for Down syndrome and trisomy 18.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syndrome; Estri | 2002 |
Maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Chro | 1992 |
Low maternal serum human chorionic gonadotrophin and unconjugated oestriol in a triploidy pregnancy.
Topics: Abortion, Therapeutic; Adult; Chorionic Gonadotropin; Chorionic Villi Sampling; Chromosome Aberratio | 1992 |
Prenatal screening for trisomy 18 in the second trimester.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estriol; Female; Humans; Pr | 1990 |
Human chorionic gonadotrophin and trisomy 18.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Estriol; Female; Hum | 1991 |
[Detection of chromosomal abnormalities using cordocentesis].
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Chr | 1991 |
Non-immunological hydrops fetalis.
Topics: Adolescent; Adult; Anemia; Blood Proteins; Congenital Abnormalities; Diabetes Complications; Edema; | 1970 |